Intermountain Healthcare and Deloitte Consulting last week announced an alliance to share data analytics and insights.
The two organizations have entered into a five-year agreement to provide health analytics insights to healthcare systems and life sciences companies.
The alliance is intended to serve as a "destination center for the insights needed to change healthcare," said Jason Girzadas, a principal at Deloitte Consulting.
The alliance, which eventually plans to include other health systems and transition to a consortium, will offer subscription- and project-based analytics and insights to healthcare providers and companies that can be used to inform the development of care interventions and treatments.
Discussions about the alliance began about a year ago, and Deloitte was chosen through an RFP process to partner with the system, according to Peter Emerson, a principal at Deloitte and former CEO of Recombinant Data Corp., which Deloitte acquired in October and has since renamed Recombinant by Deloitte.
Mr. Emerson spoke to Becker's Hospital Review about the agreement during his time at the Healthcare Information Management Systems Society Annual Conference in New Orleans this week, saying the alliance is part of a larger trend toward shared service organizations, whereby several health systems pool their resources together to reduce costs for health information management services. Hospitals that participate in the consortium would not need to purchase hardware and other data management tools individually or employ their own staff to perform data analytics. Instead, resources and costs are shared among the organizations, he says.
The alliance is part of Deloitte's overarching strategy to extend its offerings beyond consulting services to data warehousing, analytics and insights for healthcare clients. Mr. Emerson refers to this as a "hybrid strategy," and says it's a rather unique move by a firm that once focused solely on accounting, and later, consulting services.
"When I look at the landscape of folks trying to solve [healthcare] problems…none of them are solved by a tech solution alone," says Mr. Emerson. "You really need this hybrid combination to combine the technology and consulting piece and in the middle are the core partners [through the consortium] that will help inform and shape the insights needed."
The two organizations have entered into a five-year agreement to provide health analytics insights to healthcare systems and life sciences companies.
The alliance is intended to serve as a "destination center for the insights needed to change healthcare," said Jason Girzadas, a principal at Deloitte Consulting.
The alliance, which eventually plans to include other health systems and transition to a consortium, will offer subscription- and project-based analytics and insights to healthcare providers and companies that can be used to inform the development of care interventions and treatments.
Discussions about the alliance began about a year ago, and Deloitte was chosen through an RFP process to partner with the system, according to Peter Emerson, a principal at Deloitte and former CEO of Recombinant Data Corp., which Deloitte acquired in October and has since renamed Recombinant by Deloitte.
Mr. Emerson spoke to Becker's Hospital Review about the agreement during his time at the Healthcare Information Management Systems Society Annual Conference in New Orleans this week, saying the alliance is part of a larger trend toward shared service organizations, whereby several health systems pool their resources together to reduce costs for health information management services. Hospitals that participate in the consortium would not need to purchase hardware and other data management tools individually or employ their own staff to perform data analytics. Instead, resources and costs are shared among the organizations, he says.
The alliance is part of Deloitte's overarching strategy to extend its offerings beyond consulting services to data warehousing, analytics and insights for healthcare clients. Mr. Emerson refers to this as a "hybrid strategy," and says it's a rather unique move by a firm that once focused solely on accounting, and later, consulting services.
"When I look at the landscape of folks trying to solve [healthcare] problems…none of them are solved by a tech solution alone," says Mr. Emerson. "You really need this hybrid combination to combine the technology and consulting piece and in the middle are the core partners [through the consortium] that will help inform and shape the insights needed."